Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
07/1998
07/02/1998WO1998014220A3 Technetium-99m labeled chelator incorporated cyclic peptides
07/02/1998CA2274730A1 Antimicrobial proteins
07/01/1998EP0850305A2 Compounds and methods for diagnosis of tuberculosis
07/01/1998EP0804215A4 Template assembled synthetic protein
07/01/1998EP0646127B1 Polypeptide bombesin antagonists
07/01/1998EP0578728B1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIIIa
07/01/1998CN1186443A Radiolabeled peptides for diagnosis and therapy
06/1998
06/30/1998US5773602 DNA fragments obtained from a novel human immunodeficiency virus designated LAVMAL
06/30/1998US5773572 Fragments of prion proteins
06/30/1998US5773571 Peptide nucleic acids
06/30/1998US5773414 Endothelin antagonists
06/30/1998US5773413 Method of combating mammalian neoplasias, and lytic peptides therefor
06/30/1998US5773412 Use of peptides for altering αV β3 -mediated binding
06/30/1998US5773411 Cardiovascular disorders and brain disorders and coagulants
06/30/1998US5773032 Long-acting injection suspensions and a process for their preparation
06/25/1998WO1998027112A1 Cyclic peptide derivatives
06/25/1998WO1998027111A1 Vaccine for the reversible immunocastration of mammals
06/25/1998WO1998027110A2 Dihydroxypropyl cysteine peptide and agent containing this peptide
06/25/1998WO1998026795A1 Use of peptides for improving the incorporation of skin grafts
06/25/1998WO1998026794A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
06/25/1998WO1998026793A1 Synthetic antibiotics
06/25/1998WO1998010068A3 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
06/25/1998DE19653036A1 Cyclopeptidderivate Cyclopeptide derivatives
06/25/1998CA2280233A1 Cyclopeptide derivatives
06/25/1998CA2275440A1 Vaccine for the reversible immunocastration of mammals
06/25/1998CA2275213A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
06/25/1998CA2272853A1 Use of peptides for improving the incorporation of skin grafts
06/24/1998EP0848718A1 Cytolytic bradykinin antagonists
06/24/1998CN1185739A Cyclic peptide antifungal agents
06/24/1998CN1038841C Polypeptide and anti-hiv agent prepared therefrom
06/23/1998US5770722 Surface-bound, unimolecular, double-stranded DNA
06/23/1998US5770703 Nucleic acids encoding peptides of the envelope region of HIV-2 and peptides, polypeptides, and methods for producing the peptides and polypeptides of the HIV-2 envelope gene
06/23/1998US5770693 Calpain-inhibiting peptide analogs of the kininogen heavy chain
06/23/1998US5770691 Matrix metalloprotease, decapeptides
06/23/1998US5770687 Comformationally constrained backbone cyclized somatostatin analogs
06/23/1998US5770576 Administering glutamic acid-tryptophan dipeptide to stimulate binding function of t-lymphocytes
06/23/1998US5770573 CS-1 peptidomimetics, compositions and methods of using the same
06/23/1998US5770572 Methods and compositions using molecular decoyants for ameliorating the undesired effects of foreign agents which bind to endogenous receptors
06/23/1998US5770565 Peptides for reducing or inhibiting bone resorption
06/23/1998US5770563 Antiproliferative agents, antitumor agents
06/23/1998US5770456 Cyclic nucleic acid and polypeptide arrays
06/23/1998US5770455 Identifier tag which is a microchip that is pre-encoded or encodable with information that is related back to a detector when the tag is pulsed with electromagnetic radiation
06/23/1998US5770392 Method and composition for identifying inhibitors of eukaryotic cell processes
06/23/1998US5770380 Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold
06/23/1998US5770358 Tagged synthetic oligomer libraries
06/23/1998US5770178 Metal chelate forming peptides and use thereof
06/18/1998WO1998025970A1 Antithrombotic peptides derived from fibronectin type ii repeats
06/18/1998WO1998025965A2 Peptides and compounds that bind to the thrombopoietin receptor
06/18/1998WO1998025961A1 Antimicrobially active polypeptides
06/18/1998WO1998025953A1 Antimicrobial cationic peptides
06/18/1998WO1998025952A1 Peptides, methods for assaying human pepsinogen i or human pepsin i, and assay kits
06/18/1998WO1998025951A1 Inhibitors of peptide binding to mhc class ii proteins
06/18/1998WO1998025950A1 Polyprolyl inhibitors of cyclophilin
06/18/1998WO1998025584A2 Cosmetic preparation with a peptide addition
06/18/1998WO1998008956A3 Use of a mutated macrolide binding protein for the prevention of gvhd
06/18/1998WO1998006742A3 Peptides for treatment of inflammation and shock
06/18/1998DE19653736A1 Kosmetisches Präparat mit Peptidzusatz A cosmetic preparation with additional peptide
06/18/1998DE19652586A1 Dhc-Peptid und Mittel Dhc-peptide and means
06/18/1998CA2276094A1 Antimicrobially active polypeptides
06/18/1998CA2274142A1 Antithrombotic peptides derived from fibronectin type ii repeats
06/18/1998CA2271919A1 Cosmetic preparation with a peptide addition
06/18/1998CA2263828A1 Polyprolyl inhibitors of cyclophilin
06/17/1998EP0848064A1 New antibiotic, Feglymycine, process for its preparation and use of the same
06/17/1998EP0500745B1 Metal-peptide compositions and cosmetic methods for stimulating hair growth
06/17/1998CN1185209A Assaying protein fragments in body fluids
06/17/1998CN1185116A Ternary radiopharmaceutical complexes
06/17/1998CN1038751C Cyclopeptides
06/16/1998US5767288 Photolabile linkers and probes
06/16/1998US5767237 Antitumor agents
06/16/1998US5767236 Linear therapeutic peptides
06/16/1998US5767088 Useful for treating pain, inflammation, smooth muscle contraction and inducing vasodilation
06/16/1998US5767085 Peptide derivatives
06/16/1998US5767083 Inhibition of melanocyte stimulatting hormone
06/16/1998US5767082 Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
06/16/1998US5767075 Inhibiting protein interactions
06/16/1998US5767071 Sevenmer cyclic peptide inhibitors of diseases involving αv β3
06/16/1998US5767069 Cyclosporins
06/16/1998US5766855 Peptide nucleic acids having enhanced binding affinity and sequence specificity
06/16/1998US5766853 Method for identification of high affinity nucleic acid ligands to selectins
06/16/1998US5766850 Human β2 integrin α subunit
06/16/1998US5766594 Dna sequences encoding a polypeptide reactive with nti-mycoplasma gallisepticum chicken sera; expressed by a genetically engineered cell
06/13/1998CA2224025A1 Novel antibiotic, feglymycin, processes for its preparation and its use
06/11/1998WO1998024809A1 Peptides agonists of bradykinine b2 receptor
06/11/1998WO1998024807A2 Somatostatin antagonists
06/11/1998CA2273190A1 Peptides agonists of bradykinine b2 receptor
06/10/1998EP0846760A1 Production and use of anthelmintic agents and protective immunogens
06/10/1998EP0846699A1 Substance wf16616, process for production thereof, and use thereof
06/10/1998EP0846164A2 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease
06/10/1998EP0846128A2 Antimicrobial cationic peptides and methods of screening for the same
06/10/1998EP0845943A1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
06/10/1998EP0629210B1 Peptide linkage unit comprising methylene phosphinic acid
06/09/1998US5763631 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
06/09/1998US5763577 Anticarcinogenic agents
06/09/1998US5763575 Agonist and antagonist peptides of the C140 receptor
06/09/1998US5763572 HTLV-II peptide antigens
06/09/1998US5763571 Amino acid sequences which inhibit binding
06/09/1998US5763570 Glutathione analogs and paralog panels comprising glutathione mimics
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763566 Systematic evolution of ligands by exponential enrichment: tissue SELEX
06/09/1998US5763407 Cyclic peptides as antidiabetic agents
1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 423